Life Sciences and Biotechnology

Kalorama Information’s Histology and Cytology IVD Market Update report provides a comprehensive competitive analysis of the histology/cytology market from 2021 to 2026. Histology and cytology are crucial components of pathological labs, delivering vital information about cells, tissues, and organs, which are essential for diagnosing various diseases. Physicians depend heavily on these analyses for making informed…

The Voice of 841 Scientists on How They Want to Be Marketed To Online

Scientists were among the first to use the Internet to publish and share information and to communicate with each other. The suppliers of lab instruments and consumables were among the first to identify their customer’s digital behavior and respond with email…

Single Cell Analysis in Next-Generation Sequencing Markets (NGS): Market Size and Forecast, Segment Breakouts, Secondary Research, 2022-2027 delves into the rapidly growing market for single cell genomics products, including hardware, software, consumables, and services associated with sequencing and downstream analysis.

 

Report Highlights:

• Market Overview:
  • Detailed analysis of the single cell genomics market,…

Experience unparalleled insights into the rapidly evolving field of point-of-care (POC) diagnostics with Kalorama Information’s comprehensive report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition. This essential resource delves into the dramatic growth and technological innovations in POC testing, providing an in-depth analysis of the global market trends, advancements, and key players shaping…

The market for analytical and life science instrumentation in the Asia Pacific (APAC) represents around 31% of the global market. The region has been the fastest-growing market for decades, led by China. Other emerging countries, such as India and Southeast Asian countries, further fuel the growth of the market. In 2020, the challenges of the…

The At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests) report provides an in-depth analysis of the rapidly growing at-home IVD testing market. This report focuses exclusively on tests where the entire process—from sample collection to results—occurs at home, delivering results within one hour. It excludes tests that require samples to…

Kalorama Information’s The Market for Molecular Point-of-Care (mPOC), 2022 is an invaluable resource for stakeholders in the mPOC market, providing the most current and comprehensive analysis of the industry’s trends, technologies, and market dynamics, including market sizing, forecasting, trend analysis, and competitive landscape evaluation.

 

Report Highlights:

• Market Overview:
  • Detailed analysis of the…

Cardiovascular diseases, including those affecting the heart and brain’s blood vessels, are the leading cause of death globally. With the incidence of cardiovascular disease rising sharply, the demand for cardiac markers is increasing, driving constant research and development for improved diagnostics.

Kalorama Information’s World Market for Cardiac Markers (POC and Lab-Based), 2021-2026 provides crucial insights…

Stay informed with the latest trends and developments in the IVD market with IVD Trends and Market Update, March 2022 from Kalorama Information. The report reflects the latest industry insights as of Q1 2022. This comprehensive report examines the critical factors driving growth, major trends, and the ongoing impact of COVID-19 on the IVD industry.

…

Laboratory budgetary planning yields key insights into laboratory spending practices. Understanding how much laboratories plan to spend on key technologies and the distribution of those funds can provide insight into trends within an industry and help inform decision making on what technologies are being sought by laboratories. With recent uncertainty in the marketplace, knowing how…

There were over 100 billion IVD procedures in 2021.  These represent sources of revenue for IVD companies and laboratories, but they also represent gateway activities to a broad range of healthcare events including surgeries, pharmaceutical prescriptions imaging procedures and physician office visits. Finding information for procedure volumes can be difficult as companies do not publish…

The cell and gene therapy (CGT) sector has experienced remarkable growth, with funding reaching $70 billion in 2021. As barriers to entry lower and the number of approved therapies with proven track records increases, over a thousand companies have entered or expanded within this dynamic field. Keeping up with this rapidly evolving industry is essential,…